Cheryl F Lichti Selected Research

Cheryl F Lichti Research Topics

8	Neoplasms (Cancer) 01/2023 - 02/2010
4	Glioma (Gliomas) 01/2018 - 01/2014
3	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 01/2020
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 01/2014
2	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 05/2011
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Heart Failure 10/2017
1	Cognitive Dysfunction 01/2017
1	Brain Diseases (Brain Disorder) 04/2015
1	Mood Disorders (Mood Disorder) 01/2014
1	Mental Disorders (Mental Disorder) 01/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014
1	Inflammation (Inflammations) 09/2013
1	Cystic Fibrosis (Mucoviscidosis) 06/2010

6	Peptides (Polypeptides)IBA 01/2023 - 01/2018
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2010
2	LigandsIBA 01/2023 - 05/2011
2	AutoantigensIBA 01/2023 - 01/2020
2	Phosphotransferases (Kinase)IBA 04/2015 - 01/2014
2	Carrier Proteins (Binding Protein)IBA 05/2011 - 02/2010
2	Galectin 3 (LGALS3)IBA 05/2011 - 02/2010
1	AutoantibodiesIBA 01/2023
1	ProinsulinIBA 01/2020
1	Immune Checkpoint ProteinsIBA 10/2019
1	EpitopesIBA 01/2018
1	AntigensIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	ProteomeIBA 01/2018
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 10/2017
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2017
1	Rosiglitazone (Avandia)FDA Link 01/2017
1	PPAR gammaIBA 01/2017
1	ArsenicIBA 01/2016
1	Conditioned Culture MediaIBA 01/2016
1	Phosphatidic Acids (Phosphatidic Acid)IBA 06/2015
1	DiglyceridesIBA 06/2015
1	Docosahexaenoic AcidsIBA 06/2015
1	LipidsIBA 06/2015
1	Glycogen Synthase Kinase 3IBA 04/2015
1	Amino Acids FDA Link 02/2015
1	Transaminases (Aminotransferases)IBA 02/2015
1	Messenger RNA (mRNA)IBA 01/2014
1	GTP-Binding Proteins (G-Protein)IBA 01/2014
1	hypobromous acidIBA 09/2013
1	Glycoproteins (Glycoprotein)IBA 05/2011
1	S-NitrosoglutathioneIBA 06/2010
1	beta-galactosideIBA 02/2010